Search research articles
Contact Us
Filters
Showing results (151-160 of 284) with videos related to
Page
of 29
Sort By:
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy
|
July 21, 2010
Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot
J Adam Cunha, I-Chow Hsu, Jean Pouliot, et al.
The Lancet. Oncology
|
January 2, 2021
Considering benefit and risk before routinely recommending SpaceOAR
William A Hall, Alison C Tree, David Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 12, 2013
Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes
Chien Peter Chen, Vivian Weinberg, Katsuto Shinohara, et al.
Plos One
|
March 6, 2014
Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes
Maurice M Garcia, Alexander R Gottschalk, Jonathan Brajtbord, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 3, 2006
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial
Mack Roach, Michelle DeSilvio, Richard Valicenti, et al.
Plos One
|
October 7, 2016
Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes
Maurice M Garcia, Alexander R Gottschalk, Jonathan Brajtbord, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 14, 2004
Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study
Mack Roach, Kathryn Winter, Jeffrey M Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 10, 2010
Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials
George Rodrigues, Kyounghwa Bae, Mack Roach, et al.
Practical Radiation Oncology
|
March 22, 2015
Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer
Zachary A Seymour, Albert J Chang, Li Zhang, et al.
Brachytherapy
|
May 12, 2009
High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience
Siavash Jabbari, I-Chow Hsu, Jun Kawakami, et al.
Page
of 29
Search research articles
Search
Showing results (151-160 of 284) with videos related to
Sort By:
Page
of 29
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy
|
July 21, 2010
Toward adaptive stereotactic robotic brachytherapy for prostate cancer: demonstration of an adaptive workflow incorporating inverse planning and an MR stealth robot
J Adam Cunha, I-Chow Hsu, Jean Pouliot, et al.
The Lancet. Oncology
|
January 2, 2021
Considering benefit and risk before routinely recommending SpaceOAR
William A Hall, Alison C Tree, David Dearnaley, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 12, 2013
Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes
Chien Peter Chen, Vivian Weinberg, Katsuto Shinohara, et al.
Plos One
|
March 6, 2014
Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes
Maurice M Garcia, Alexander R Gottschalk, Jonathan Brajtbord, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 3, 2006
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial
Mack Roach, Michelle DeSilvio, Richard Valicenti, et al.
Plos One
|
October 7, 2016
Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes
Maurice M Garcia, Alexander R Gottschalk, Jonathan Brajtbord, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 14, 2004
Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study
Mack Roach, Kathryn Winter, Jeffrey M Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 10, 2010
Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials
George Rodrigues, Kyounghwa Bae, Mack Roach, et al.
Practical Radiation Oncology
|
March 22, 2015
Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer
Zachary A Seymour, Albert J Chang, Li Zhang, et al.
Brachytherapy
|
May 12, 2009
High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience
Siavash Jabbari, I-Chow Hsu, Jun Kawakami, et al.
Page
of 29